Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Overview
  • Distribution
  • Guaranteed Paid Placement
  • SocialBoost
  • Multichannel Amplification
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Overview
  • Distribution by PR Newswire
  • Guaranteed Paid Placement
  • SocialBoost
  • Multichannel Amplification
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

Research from XJTLU advances RNA modification mapping
  • USA - English
  • USA - español
  • USA - Deutsch
  • USA - Français
  • Latin America - español
  • Brazil - Português


News provided by

Xi'an Jiaotong-Liverpool University

21 Mar, 2019, 14:24 IST

Share this article

Share toX

Share this article

Share toX

SUZHOU, China, March 21, 2019 /PRNewswire/ -- Researchers from Xi'an Jiaotong-Liverpool University have completed a high-resolution prediction of the whole-transcriptome m6A RNA modification, successfully creating the world's most accurate map of the m6A epitranscriptome.

Led by Dr Jia Meng from the Department of Biological Sciences, the research was recently published in Nucleic Acids Research.

Dr Meng says the results may have promising implications for a range of diseases.

"It's hard to predict which diseases will benefit from the research into m6A RNA methylation but studies indicate the enzymes of m6A RNA methylation play a key role in leukemia, lung cancer and breast cancer," he says.

"As a fundamental layer of gene regulation, I wouldn't be surprised to see epitranscriptome regulation through reversible m6A RNA methylation playing an important role in many diseases.

"Cancer is proving to be a promising direction to explore further."

Dr Meng says RNA stands for ribonucleic acid – known as the 'cousin' of DNA – and that m6A RNA modification is a type of biochemical modification of RNA molecules, which can alter their biological properties and regulate gene expression without changing its sequences.

"Previously the accuracy of m6A RNA modification site prediction could only reach approximately 80 percent using conventional sequence information," he says.

"What we found is that by adding 35 additional genomic features, we can increase the accuracy to 90 per cent, which is a big step forward."

Dr Meng says it's a hot topic in biological science today, as there are more than 100 different types of RNA modifications, and their functions are largely unknown.

According to Dr Meng, the m6A is the most abundant and is likely to be the most valuable to study.

The research team used a machine-learning approach when drafting the map of the m6A epitranscriptome, establishing a prediction model based on the conventional sequence features and new genomic features to predict the precise locations on genes that might be related to RNA modifications.

PhD student Kunqi Chen says more accurate predictions and a better understanding of the site of the RNA modifications allow scientists to more easily identify which enzymes are involved in the process.

"Our work contributes to the study of genetic functions and traits, and the relationship between genes and some human diseases," he says.

Modal title

Also from this source

XJTLU-Baidu AI joint venture launched

On 26 March, Suzhou Pudu Co-Intelligence Technology Company, a joint venture between Xi'an Jiaotong-Liverpool University (XJTLU) and Baidu Group, was ...

More Releases From This Source

Explore

Education

Education

Biotechnology

Biotechnology

Health Care & Hospitals

Health Care & Hospitals

STEM (Science, Tech, Engineering, Math)

STEM (Science, Tech, Engineering, Math)

News Releases in Similar Topics

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.